Pharmacogenetics: The Dx perspective

Expert Review of Molecular Diagnostics

Volumn 1, Issue 4, 2001, Pages 371-376

  Cartwright, Charles P ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Detection; Genome; Microatray; PCR; Pharmacogenetics; Sequencing; Variation

Indexed keywords

ACCURACY; AUTOANALYSIS; CLINICAL LABORATORY; DRUG RESPONSE; GENETIC VARIABILITY; HUMAN; MEDICAL TECHNOLOGY; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; QUANTITATIVE ANALYSIS; REVIEW; SEQUENCE ANALYSIS; ARTICLE; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; DNA SEQUENCE; GENETICS; MASS SPECTROMETRY; METHODOLOGY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPECTROFLUOROMETRY;

LIGASE;

HUMANS; LIGASES; MASS SPECTROMETRY; MOLECULAR DIAGNOSTIC TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOGENETICS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, FLUORESCENCE;

EID: 0035527707     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.1.4.371     Document Type: Review

References (45)

1. The role of nucleic acid amplification and detection in the clinical microbiology laboratory
2. Molecular diagnostics
3. x perspective
4. New goals for the US human genome project: 1998-2003
5. Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions?
6. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs
7. Nucleic acid amplification technologies
8. Miniaturization technologies for molecular diagnostics
9. Simultaneous polymerase chain reaction restriction fragment length polymorphism idenfication of the Factor V leiden allele and the prothrombin 20210A mutation
10. Mutation detection in K-ras, BRCA1, BRCA2 and p53 using PCR/ LDR and a universal DNA microarray
11. Specific, sensitive and rapid assay for human immunodeficiency virus Type 1 pol mutations associated with resistance to zidovudine and didanosine
12. Detection and quantification of the A3243G mutation of mitochondrial DNA by ligation detection reaction
13. Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry
14. Enabling large-scale pharmacogenetic studies by high- throughput mutation detection and genotyping technologies
15. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
16. Multiplex detection of single-nudeotide variations using molecular beacons
17. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay
18. Large-scale single nucleotide polymorphisms scoring from unamplified genomic DNA
19. Genotyping of Factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes
20. Combining nucleic acid amplification and detection
21. Recent developments in DNA sequencing by capillary and microdevice electrophoresis
22. Pyrosequencing sheds light on DNA sequencing
23. Mutational analysis using oligonucleotide microarrays
24. DNA chips: State-of-the art
25. Large-scale identification, mapping and genotyping of single-nucleotide polymorphisms in the human genome
26. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays
27. Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays
28. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-color fluorescence analysis
29. Genotyping by mass spectrometric analysis of short DNA fragments
30. Detecting CFTR gene mutations using primer oligo base extension and mass spectrometry
31. HIV viral dynamics
32. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
33. Comparative evaluation of three human immunodeficiency virus genotyping systems: The HIV-GenotypR method, the HIV PRT GeneChip assay and the HIV-1 RT line probe assay
34. Human immunodeficiency virus Type 1 drug resistance testing: A comparison of three sequence-based methods
35. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
36. Drug resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
37. Prevalence of genotypic and phenotypic resistance to antiretroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel
38. Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: Applications to a clinical trial
39. The use of HER2 testing in the management of breast cancer
40. The long-term prognostic significance of c-erbB-2 in primary breast cancer
41. c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy
42. Pharmacology and therapeutic use of trastuzumab in breast cancer
43. Electronic detection of nucleic acids: A versatile platform for molecular diagnostics
44. Impact of pharmacogenomics on the clinical laboratory
45. Pharmacogenomics: A clinicians primer on emerging technologies for improved patient care